JP2025118775A5 - - Google Patents
Info
- Publication number
- JP2025118775A5 JP2025118775A5 JP2025076816A JP2025076816A JP2025118775A5 JP 2025118775 A5 JP2025118775 A5 JP 2025118775A5 JP 2025076816 A JP2025076816 A JP 2025076816A JP 2025076816 A JP2025076816 A JP 2025076816A JP 2025118775 A5 JP2025118775 A5 JP 2025118775A5
- Authority
- JP
- Japan
- Prior art keywords
- formula
- linker
- pharmaceutically acceptable
- pharmaceutical composition
- radical
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (6)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202062958102P | 2020-01-07 | 2020-01-07 | |
| US62/958,102 | 2020-01-07 | ||
| US202063030020P | 2020-05-26 | 2020-05-26 | |
| US63/030,020 | 2020-05-26 | ||
| PCT/US2021/012532 WO2021142145A1 (en) | 2020-01-07 | 2021-01-07 | Targeted steroid conjugates |
| JP2022541787A JP7678813B2 (ja) | 2020-01-07 | 2021-01-07 | 標的指向性ステロイド化合物 |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022541787A Division JP7678813B2 (ja) | 2020-01-07 | 2021-01-07 | 標的指向性ステロイド化合物 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2025118775A JP2025118775A (ja) | 2025-08-13 |
| JP2025118775A5 true JP2025118775A5 (https=) | 2026-03-19 |
Family
ID=76787625
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022541787A Active JP7678813B2 (ja) | 2020-01-07 | 2021-01-07 | 標的指向性ステロイド化合物 |
| JP2025076816A Pending JP2025118775A (ja) | 2020-01-07 | 2025-05-02 | 標的指向性ステロイド化合物 |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022541787A Active JP7678813B2 (ja) | 2020-01-07 | 2021-01-07 | 標的指向性ステロイド化合物 |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US20230331767A1 (https=) |
| EP (1) | EP4087580A4 (https=) |
| JP (2) | JP7678813B2 (https=) |
| KR (1) | KR20220124742A (https=) |
| CN (1) | CN115003308A (https=) |
| AU (1) | AU2021205255A1 (https=) |
| BR (1) | BR112022013478A2 (https=) |
| CA (1) | CA3163268A1 (https=) |
| IL (2) | IL326516A (https=) |
| MX (1) | MX2022008343A (https=) |
| WO (1) | WO2021142145A1 (https=) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN115232186B (zh) * | 2022-07-07 | 2024-03-01 | 武汉工程大学 | 一种泼尼松磷酸酯及其盐的制备方法和应用 |
| WO2024025845A1 (en) * | 2022-07-25 | 2024-02-01 | Sorrento Therapeutics, Inc. | Folate-conjugated drugs and uses thereof |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6379698B1 (en) * | 1999-04-06 | 2002-04-30 | Isis Pharmaceuticals, Inc. | Fusogenic lipids and vesicles |
| CA2503094A1 (en) * | 2002-02-27 | 2003-09-04 | The Ohio State University Research Foundation | Therapeutic methods for acute myeloid leukemia |
| US20070009434A1 (en) * | 2005-07-05 | 2007-01-11 | Low Philip S | Imaging and therapeutic method using monocytes |
| WO2007139815A2 (en) * | 2006-05-23 | 2007-12-06 | Purdue Research Foundation | Imaging and therapeutic method using progenitor cells |
| EP2231194B1 (en) * | 2007-12-04 | 2017-02-22 | Alnylam Pharmaceuticals Inc. | Folate-irna conjugates |
| CA2800693A1 (en) * | 2010-05-28 | 2011-12-01 | Purdue Research Foundation | Delivery of therapeutic agents to inflamed tissues using folate-targeted agents |
| EP2908818A4 (en) * | 2012-10-16 | 2016-07-13 | Endocyte Inc | CONJUGATES OF DRUG DELIVERY CONTAINING ARTIFICIAL AMINO ACIDS AND METHODS OF USE |
| MY195114A (en) * | 2016-02-04 | 2023-01-10 | Robert Yongxin Zhao | Specific Conjugation Linkers, Specific Immunoconjugates Thereof, Methods of Making and uses Such Conjugates Thereof |
| CA3042442C (en) * | 2016-11-14 | 2024-01-02 | Hangzhou Dac Biotech Co., Ltd | Conjugation linkers, cell binding molecule-drug conjugates containing the linkers, methods of making and uses of such conjugates with the linkers |
-
2021
- 2021-01-07 US US17/758,492 patent/US20230331767A1/en active Pending
- 2021-01-07 CA CA3163268A patent/CA3163268A1/en active Pending
- 2021-01-07 EP EP21738610.1A patent/EP4087580A4/en active Pending
- 2021-01-07 CN CN202180008293.6A patent/CN115003308A/zh active Pending
- 2021-01-07 MX MX2022008343A patent/MX2022008343A/es unknown
- 2021-01-07 BR BR112022013478A patent/BR112022013478A2/pt unknown
- 2021-01-07 AU AU2021205255A patent/AU2021205255A1/en active Pending
- 2021-01-07 JP JP2022541787A patent/JP7678813B2/ja active Active
- 2021-01-07 KR KR1020227026839A patent/KR20220124742A/ko active Pending
- 2021-01-07 WO PCT/US2021/012532 patent/WO2021142145A1/en not_active Ceased
- 2021-01-07 IL IL326516A patent/IL326516A/en unknown
-
2022
- 2022-06-27 IL IL294339A patent/IL294339B1/en unknown
-
2025
- 2025-05-02 JP JP2025076816A patent/JP2025118775A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2025118775A5 (https=) | ||
| JP2021063088A5 (https=) | ||
| JP2025116875A5 (https=) | ||
| JP2021100937A5 (https=) | ||
| JP2006182786A5 (https=) | ||
| CN113365998A (zh) | 用于parp抑制剂的吲哚并七元酰肟类似物 | |
| JP2008501705A5 (https=) | ||
| JP2020507589A5 (https=) | ||
| JP2003507438A5 (https=) | ||
| JP2010522756A5 (https=) | ||
| JPWO2022016070A5 (https=) | ||
| CN110612143B (zh) | 抗微生物化合物、组合物及其用途 | |
| JP2011505356A5 (https=) | ||
| JP2021534160A5 (https=) | ||
| JP2003519228A5 (https=) | ||
| WO2014129495A1 (ja) | 眼疾患処置薬 | |
| JP2010505865A5 (https=) | ||
| JP2017522304A5 (https=) | ||
| JP2003520208A5 (https=) | ||
| JPWO2021093839A5 (https=) | ||
| JP2020533402A5 (https=) | ||
| JP2008533135A (ja) | ゲムシタビン誘導体の経口投薬形態 | |
| JPWO2023078333A5 (https=) | ||
| JP2010528088A5 (https=) | ||
| JP2008513417A (ja) | ロフルミラスト又はロフルミラストのｎ−オキシドを含有する医薬組成物 |